Mercer Global Advisors
RLYB icon

Mercer Global Advisors’s Rallybio RLYB Stock Holding History

Mercer Global Advisors’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,250
Closed -$6.86K – 3323
2025
Q4 		$6.86K Hold
1,250
– – ﹤0.01% 2837
2025
Q3 		$4.99K Hold
1,250
– – ﹤0.01% 2631
2025
Q2 		$3.38K Hold
1,250
– – ﹤0.01% 2248
2025
Q1 		$6.54K Hold
1,250
– – ﹤0.01% 2142
2024
Q4 		$9.6K Buy
+1,250
New +$10.5K ﹤0.01% 2112
2024
Q2 		– Sell
-1,250
Closed -$19K – 2033
2024
Q1 		$19K Buy
+1,250
New +$17.4K ﹤0.01% 1923
2023
Q4 		– Sell
-1,250
Closed -$34K – 2078
2023
Q3 		$34K Hold
1,250
– – ﹤0.01% 1907
2023
Q2 		$57K Hold
1,250
– – ﹤0.01% 1863
2023
Q1 		$57K Buy
+1,250
New +$64.6K ﹤0.01% 1865
2022
Q3 		– Sell
-1,250
Closed -$76K – 1898
2022
Q2 		$76K Buy
+1,250
New +$93.9K ﹤0.01% 1748

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Mercer Global Advisors's RLYB Position: Q1 2026 in Review

Mercer Global Advisors sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 1,250 shares — an estimated $6.86K sold.

Mercer Global Advisors first reported a position in RLYB in Q2 2022 and held it in 10 quarters. The position peaked at $76K in Q2 2022. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Mercer Global Advisors reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 1,250 Rallybio shares in Q1 2026, an estimated $6.86K.
  • Mercer Global Advisors first reported a position in Rallybio in Q2 2022 and held it in 10 quarters.
  • Mercer Global Advisors's Rallybio position peaked at $76K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.